General advice has not yet released the 2011 China medical device Industry Analysis and Development Forecast Report. The report notes that \"five-second\" period, China\\ s medical device industry, there is a big space for development, that in 2015 China\\ s entire medical instruments and equipment market is expected to double, reaching $ 53.7 billion, the Chinese medical device industry compound annual growth rate maintained at 20% to 30%, industry has great potential.
It is still common consulting analyst forecasts, to the \"second five\" at the end, that in 2015 China\\ s entire medical instruments and equipment market is expected to double, reaching $ 53.7 billion, the Chinese medical device industry compound annual growth rate will remain at 20% to 30%, industry has great potential. For example, he shows that \"the current county-level hospitals and township hospitals 80,000 more than the equipment purchase, renovation, replacement demand a huge gap.\"
Investment in Securities believes that China\\ s medical device market share of total pharmaceutical market size of 14% and 42% far from the global level; devices with global per capita consumption level, China has five to six times the room for improvement; of health care expenses as a percentage about 5% of GDP, well below the U.S. 16%; upgrade aging ﹑ consumption and government investment in long-term support for the medical device industry.
June 13, 2011 issued by the Ministry of Health in April 2011 and a quarter of medical services, the data show that the industry is running well, the construction of clinic visits and health institutions are to maintain stable growth, industry growth trends to determine; according to data released by the Ministry of Health, January to April 2011, total national health agency clinic visits over 1.867 billion people, an increase of 10.25%.
Qilu Securities pointed out that the overall valuation of pharmaceutical stocks has been lower than the average level since 2004, according to forecast earnings for the calculation of the current valuation of 25 times the pharmaceutical sector, which of the drug 22 times PE, medicine and biology 28 times PE, medical devices 23 times PE, and the current valuation of pharmaceutical stocks in the bottom of the Opening of the best time, proposes a focus on heavy volume and has a primary benefit of exclusive varieties Tasly, donkey-hide gelatin, Yunnanbaiyao, SL Pharmaceutical and medical benefit Xinhua medical institution-building, diving medical
Meanwhile, Minsheng Securities also pointed out that 2011 is the new medical reform to achieve milestones of the year ending 2011, the new health reform requires a comprehensive basic medical insurance system covering urban and rural residents, the initial establishment of the basic drug system, urban and rural primary care health service system further improved, basic public health services have been popular, reform of public hospitals to achieve a breakthrough, significantly improve the basic health services accessibility, cost effective medical treatment to reduce the burden on residents. From the new medical reform scheduled completion date, less than 5 months. Speed ??and tackling, a \"wrap up\" before the two key words. As the new medical reform will soon ending, the recent medical reform movements are frequent throughout. Medical industry is a positive change. They believe that participation in health care information technology companies will be a huge market opportunity, the recommended companies include: Wei-ning software, Wanda information, easy to Lianzhong, and recommended that attention Neusoft Group, Silver River shares, UF software.